InNexus Biotechnology (InNexus Biotechnology) Change In Payables And Accrued Expense : $0.73 Mil (TTM As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Change In Payables And Accrued Expense?

InNexus Biotechnology's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2011 was $0.09 Mil. It means InNexus Biotechnology's Accounts Payable & Accrued Expense increased by $0.09 Mil from Dec. 2010 to Mar. 2011 .

InNexus Biotechnology's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2010 was $1.23 Mil. It means InNexus Biotechnology's Accounts Payable & Accrued Expense increased by $1.23 Mil from Jun. 2009 to Jun. 2010 .

InNexus Biotechnology Change In Payables And Accrued Expense Historical Data

The historical data trend for InNexus Biotechnology's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Change In Payables And Accrued Expense Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.01

0.45

0.08

2.01

1.23

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															0.57	0.42	0.09	0.13	0.09

InNexus Biotechnology Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.73 Mil.

InNexus Biotechnology Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines